Synthesis and antidyslipidemic activity of chalcone fibrates

A series of chalcone based PPAR-α agonists were synthesized and evaluated for their antidyslipidemic activity in high fructose high fat fed dyslipidemic Syrian golden hamsters. Most of the compounds exhibited antidyslipidemic activity. The compounds 4c and 4f have been identified as most potent antidyslipidemics. A definite structure-activity relationship was observed while varying the nature as well as the position of the substituent.     

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism

Gut microbiota dysbiosis has been implicated in a variety of systemic disorders, notably metabolic diseases including obesity and impaired liver function, but the underlying mechanisms are uncertain. To investigate this question, we transferred caecal microbiota from either obese or lean mice to antibiotic‐free, conventional wild‐type mice. We found that transferring obese‐mouse gut microbiota to mice on normal chow (NC) acutely reduces markers of hepatic gluconeogenesis with decreased hepatic PEPCK activity, compared to non‐inoculated mice, a phenotypic trait blunted in conventional NOD2 KO mice. Furthermore, transferring of obese‐mouse microbiota changes both the gut microbiota and the microbiome of recipient mice. We also found that transferring obese gut microbiota to NC‐fed mice then fed with a high‐fat diet (HFD) acutely impacts hepatic metabolism and prevents HFD‐increased hepatic gluconeogenesis compared to non‐inoculated mice. Moreover, the recipient mice exhibit reduced hepatic PEPCK and G6Pase activity, fed glycaemia and adiposity. Conversely, transfer of lean‐mouse microbiota does not affect markers of hepatic gluconeogenesis. Our findings provide a new perspective on gut microbiota dysbiosis, potentially useful to better understand the aetiology of metabolic diseases.     

Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice

ABSTRACT

Dietary capsaicin exhibits anti-steatosis activity in obese mice. High-fat diet (HFD)-induced mice is a highly studied approach to develop non-alcoholic fatty liver disease (NAFLD). In this study, we determined whether the topical application of capsaicin can improve lesions of NAFLD. The HFD-induced mice were treated with daily topical application of capsaicin for 8 weeks. Topical application of capsaicin reduced liver fat in HFD-fed mice. Capsaicin stimulated carnitine palmitoyl transferase (CPT)-1 and CD36 expression, which are associated with β-oxidation and fatty acids influx of liver while it decreased the expression of key enzymes involved in the synthesis of fatty acids, such as acetyl Co-A carboxylase (ACC) and fatty acid synthase (FAS). Immunohistochemical analysis revealed the elevated level of adiponectin in liver tissue of the capsaicin-treated mice. These results suggest that the topical application of capsaicin suppresses liver fat accumulation through the upregulation of β-oxidation and de novo lipogenesis in HFD-induced NAFLD mice.     

高脂饮食对小鼠胃蛋白质组表达水平的影响

以高脂饮食小鼠为模型,多角度分析高脂饮食对小鼠胃蛋白组表达的影响。实验小鼠(C57BL/6)随机分配两组,实验组食用高脂饲料,对照组食用正常饲料,喂养110d后,把胃组织分为前胃、胃体和胃窦3个区分别进行蛋白质谱鉴定,随后比较两组实验的蛋白表达谱,分别筛选两组之间的差异蛋白以及胃分区的差异蛋白(差异倍数≥2),并对其进行GO富集及蛋白相互作用网络分析。对照组和实验组共鉴定到9 307种蛋白,筛选特异性肽段≥1且重复实验中至少鉴定到2次的蛋白,最后剩余4 066种蛋白,其中对照组3654种,实验组3832种。进一步从生物功能角度整体分析了胃组织的蛋白表达谱,结果发现实验组小鼠胃组织中高表达蛋白主要参与蛋白稳定和运输等生物学过程。而在对胃分区差异蛋白的功能分析表明,前胃主要参与角质化和肌动蛋白组装相关生物学过程,且受饮食影响程度较小;胃体和胃窦主要执行消化功能,高脂饮食后对胃的基本消化功能并无显著影响,但与对照组相比,参与蛋白转运和脂肪代谢相关生物学过程的蛋白显著高表达。